Influenza Vaccines (immunology) And NotAurore Ducastel
List of bibliographic references
Number of relevant bibliographic references: 15.| Ident. | Authors (with country if any) | Title |
|---|---|---|
| 000387 | Julie Medina [France] ; Houda Boukhebza [France] ; Amélie De Saint Jean [France] ; Régis Sodoyer [France] ; Isabelle Legastelois [France] ; Catherine Moste [France] | Optimization of influenza A vaccine virus by reverse genetic using chimeric HA and NA genes with an extended PR8 backbone. |
| 000439 | Olivia Bonduelle [France] ; Fabrice Carrat [France] ; Charles-Edouard Luyt [France] ; Catherine Leport [France] ; Anne Mosnier [France] ; Nora Benhabiles [France] ; Anne Krivine [France] ; Flore Rozenberg [France] ; Nora Yahia [France] ; Assia Samri [France] ; Dominique Rousset [France] ; Sylvie Van Der Werf [France] ; Brigitte Autran [France] ; Behazine Combadiere [France] | Characterization of pandemic influenza immune memory signature after vaccination or infection |
| 000587 | Marcus J. Korth [États-Unis] ; Nicolas Tchitchek [États-Unis] ; Arndt G. Benecke [France] ; Michael G. Katze [États-Unis] | Systems approaches to influenza-virus host interactions and the pathogenesis of highly virulent and pandemic viruses |
| 000589 | Norberto Giglio [Argentine] ; Angela Gentile [Argentine] ; Lydia Lees [Royaume-Uni] ; Paula Micone [Argentine] ; Judith Armoni [Argentine] ; Camille Reygrobellet [France] ; Pascal Crepey [France] | Public health and economic benefits of new pediatric influenza vaccination programs in Argentina |
| 000593 | Jean-Paul Guthmann [France] ; Laure Fonteneau ; Isabelle Bonmarin ; Daniel Lévy-Bruhl | Influenza vaccination coverage one year after the A(H1N1) influenza pandemic, France, 2010-2011. |
| 000594 | B. Rousseau [France] ; P. Loulergue ; O. Mir ; A. Krivine ; S. Kotti ; E. Viel ; T. Simon ; A. De Gramont ; F. Goldwasser ; O. Launay ; C. Tournigand | Immunogenicity and safety of the influenza A H1N1v 2009 vaccine in cancer patients treated with cytotoxic chemotherapy and/or targeted therapy: the VACANCE study. |
| 000683 | P. Tuppin [France] ; S. Samson ; A. Weill ; P. Ricordeau ; H. Allemand | Seasonal influenza vaccination coverage in France during two influenza seasons (2007 and 2008) and during a context of pandemic influenza A(H1N1) in 2009. |
| 000781 | Marc P. Girard [France] ; John S. Tam ; Olga M. Assossou ; Marie Paule Kieny | The 2009 A (H1N1) influenza virus pandemic: A review. |
| 000790 | Guangyu Zhao [République populaire de Chine] ; Shihui Sun [République populaire de Chine] ; Lanying Du [États-Unis] ; Wenjun Xiao [République populaire de Chine] ; Zhitao Ru [République populaire de Chine, France] ; Zhihua Kou [République populaire de Chine] ; Yan Guo [République populaire de Chine] ; Hong Yu [République populaire de Chine] ; Shibo Jiang [États-Unis] ; Yuchun Lone [France] ; Bo-Jian Zheng [République populaire de Chine] ; Yusen Zhou [République populaire de Chine] | An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus |
| 000831 | Michaël Schwarzinger [France] ; Pierre Verger [France] ; Marc-André Guerville [France] ; Catherine Aubry [France] ; Sophie Rolland [France] ; Yolande Obadia [France] ; Jean-Paul Moatti [France] | Positive attitudes of French general practitioners towards A/H1N1 influenza-pandemic vaccination: A missed opportunity to increase vaccination uptakes in the general public? |
| 000937 | Tawee Chotpitayasunondh [Thaïlande] ; Usa Thisyakorn [Thaïlande] ; Chitsanu Pancharoen [Thaïlande] ; Stephanie Pepin [France] ; Nolwenn Nougarede [France] | Safety, Humoral and Cell Mediated Immune Responses to Two Formulations of an Inactivated, Split-Virion Influenza A/H5N1 Vaccine in Children |
| 000938 | David S. Fedson [France] | NEW technologies for meeting the global demand for pandemic influenza vaccines. |
| 000942 | Marc-André D Oust ; Pierre-Olivier Lavoie ; Manon M. Couture ; Sonia Trépanier ; Jean-Martin Guay ; Michèle Dargis ; Sébastien Mongrand [France] ; Nathalie Landry ; Brian J. Ward ; Louis-P. Vézina | Influenza virus‐like particles produced by transient expression in Nicotiana benthamiana induce a protective immune response against a lethal viral challenge in mice |
| 000988 | Azizul Haque [France, États-Unis] ; Didier Hober [États-Unis] ; Lloyd H. Kasper [États-Unis] | Confronting Potential Influenza A (H5N1) Pandemic with Better Vaccines |
| 000A23 | Jean-Louis Bresson [France] ; Christian Perronne ; Odile Launay ; Catherine Gerdil ; Melanie Saville ; John Wood ; Katja Höschler ; Maria C. Zambon | Safety and immunogenicity of an inactivated split-virion influenza A/Vietnam/1194/2004 (H5N1) vaccine: phase I randomised trial. |
| This area was generated with Dilib version V0.6.34. |  |